WG
VBIV

Winton Group’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Winton Group’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-337
Closed -$31K – 1478
2021
Q3 		$31K Buy
+337
New +$32K ﹤0.01% 1313
2020
Q1 		– Sell
-6,114
Closed -$253K – 1574
2019
Q4 		$253K Buy
6,114
+1,675
+38% +$36.7K ﹤0.01% 1405
2019
Q3 		$63K Buy
+4,439
New +$93K ﹤0.01% 1490

Other funds holding VBIV

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Winton Group's VBIV Position: Q4 2021 in Review

Winton Group sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q4 2021, closing a stake of 337 shares — an estimated $31K sold.

Winton Group first reported a position in VBIV in Q3 2019 and held it in 3 quarters. The position peaked at $253K in Q4 2019. 134 funds tracked by Wall St. Rank hold VBIV as of Q4 2021.

  • Winton Group reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q4 2021 after selling out during the quarter.
  • Winton Group sold 337 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q4 2021, an estimated $31K.
  • Winton Group first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q3 2019 and held it in 3 quarters.
  • Winton Group's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $253K in Q4 2019.
  • 134 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q4 2021.

Based on Winton Group's 13F filing for Q4 2021, filed 10 Feb 2022.